BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 16525591)

  • 21. Recombinant tissue plasminogen activator for both pulmonary and cerebral embolism.
    Yeguiayan JM; Benatru I; Guiu B; Taam JA; Albertini S; Freysz M; Giroud M
    Am J Emerg Med; 2011 Oct; 29(8):961.e1-4. PubMed ID: 21030188
    [No Abstract]   [Full Text] [Related]  

  • 22. Adjunctive therapy in coronary thrombolysis: prostaglandins, nitrates and calcium antagonists.
    Fitzgerald D
    Coron Artery Dis; 1995 Dec; 6(12):940-6. PubMed ID: 8723016
    [No Abstract]   [Full Text] [Related]  

  • 23. Double treatment of severe hepatic veno-occlusive disease after allogeneic peripheral blood progenitor cell transplantation with recombinant tissue plasminogen activator.
    Söhngen D; Bauser U; Boogen C; Aul C; Frieling T; Germing U; Schneider P; Kobbe G; Heyll A
    Thromb Haemost; 1997 Oct; 78(4):1299-300. PubMed ID: 9365005
    [No Abstract]   [Full Text] [Related]  

  • 24. The prospects and predicaments of intravenous rt-PA in childhood ischemic stroke.
    Behrouz R
    Expert Rev Neurother; 2014 Mar; 14(3):255-9. PubMed ID: 24491039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retinal arterial occlusion with LIF using rTPA.
    Hayreh SS
    Ophthalmology; 1999 Jul; 106(7):1236-9. PubMed ID: 10406599
    [No Abstract]   [Full Text] [Related]  

  • 26. Thrombolytic therapy in adult meningococcal purpura fulminans with acute renal failure and severe perfusion deficits to the extremities.
    Pechlaner C; Buratti T; Biedermann H; Joannidis M; Wiedermann CJ
    Wien Klin Wochenschr; 1999 Sep; 111(16):650-4. PubMed ID: 10510843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thrombolysis in capsular warning syndrome.
    Vivanco-Hidalgo RM; Rodriguez-Campello A; Ois A; Cucurella G; Pont-Sunyer C; Gomis M; Cuadrado-Godia E; Roquer J
    Cerebrovasc Dis; 2008; 25(5):508-10. PubMed ID: 18477844
    [No Abstract]   [Full Text] [Related]  

  • 28. Pneumococcal purpura fulminans successfully treated with activated protein C.
    Minhas KM; Bashir S; Sarwari AR; Parker J
    South Med J; 2008 Oct; 101(10):1046-8. PubMed ID: 18791506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Thrombolytic therapy of deep venous thrombosis. Indications, treatment procedures].
    Theiss W
    Internist (Berl); 1992 Apr; 33(4):225-31. PubMed ID: 1612846
    [No Abstract]   [Full Text] [Related]  

  • 30. Human recombinant tissue-plasminogen activator (alteplase): why not use the 'human' dose for stroke studies in rats?
    Haelewyn B; Risso JJ; Abraini JH
    J Cereb Blood Flow Metab; 2010 May; 30(5):900-3. PubMed ID: 20216551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful treatment of a catheter-related right atrial thrombosis with recombinant tissue plasminogen activator and heparin.
    Cesaro S; Paris M; Corrò R; Svaluto G; Zanon GF; Gamba P; Milanesi O; Messina C; Zanesco L
    Support Care Cancer; 2002 Apr; 10(3):253-5. PubMed ID: 11904791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant peptides in thrombolysis.
    Campbell J; Hilleman D
    Semin Thromb Hemost; 2010 Jul; 36(5):529-36. PubMed ID: 20632250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombinant tissue plasminogen activator in children with meningococcal purpura fulminans--role uncertain.
    Baines P; Carrol ED
    Crit Care Med; 2004 Aug; 32(8):1806-7. PubMed ID: 15286574
    [No Abstract]   [Full Text] [Related]  

  • 34. [Thrombolysis for acute ischemic stroke with recombinant tissue plasminogen activator in a Chilean public hospital].
    Figueroa-Reyes T; Sáez M D; Mansilla L E; Sánchez V R; Nogales-Gaete J; Delgado B I
    Rev Med Chil; 2011 Sep; 139(9):1118-27. PubMed ID: 22215389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Purpura fulminans due to pneumococcal pneumonia in a healthy adult: a case report].
    Takada K; Matsumoto S; Hiramatsu T; Kojima E; Watanabe H
    Kansenshogaku Zasshi; 2007 Mar; 81(2):194-9. PubMed ID: 17447479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coronary thrombolysis and the new biology.
    Sobel BE
    J Am Coll Cardiol; 1989 Oct; 14(4):850-60. PubMed ID: 2507611
    [No Abstract]   [Full Text] [Related]  

  • 37. Is recombinant tissue plasminogen activator an option in the treatment of meningococcus-induced purpura?
    Veldman A; Ehrenberg A; Jäger G; Ettingshausen CE; Schneider W; Kreuz W
    Crit Care Med; 2000 Feb; 28(2):598-600. PubMed ID: 10708220
    [No Abstract]   [Full Text] [Related]  

  • 38. Images in cardiology Coronary artery spasm.
    Johnston PW; Webb SW
    Heart; 1999 Apr; 81(4):448-9. PubMed ID: 10092581
    [No Abstract]   [Full Text] [Related]  

  • 39. Recombinant tissue plasminogen activator for the treatment of cutaneous infarctions in antiphospholipid antibody syndrome: a case report.
    Srinivasan SK; Pittelkow MR; Cooper LT
    Angiology; 2001 Sep; 52(9):635-9. PubMed ID: 11570663
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Where are we with purpura fulminans?].
    Huault G
    Arch Pediatr; 1998 Oct; 5(10):1061-4. PubMed ID: 9809147
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.